Asset / Drug

Clinical

Drug and asset intelligence for Clinical with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Stage: Development stage unavailable

Sponsor company

SARS-Cov-2 →

Recent signals(2)

ClinicalJune 21, 2026

Clinical Trial on Anti-inflammatory Diet's Impact on Type 2 Diabetes Management

A randomized controlled trial is evaluating the effects of an anti-inflammatory dietary intervention on inflammation and glycemic control in patients with type 2 diabetes.

ClinicalJune 11, 2026

Clinical Trial Evaluates PRS CK STORM for Cytokine Storm in Respiratory Infections

A clinical trial is assessing the safety and efficacy of PRS CK STORM in patients with cytokine storms from respiratory infections.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

Infectious Disease →

Type 2 Diabetes →

Therapeutic areas

Cytokine Modulation →

Endocrinology →

Infectious Disease →

Type 2 Diabetes →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.